Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P234: Changing natural history in IBD – steroid-free remission and surgery in two cohorts (≤2009 and > 2009) – an interplay between disease pattern, biologics and adherenceECCO '18 Vienna
Year: 2018
Authors:

A. Viola1*, M. Naim1, M. Scolaro1, T. Pinto-Vraca1, A. Belvedere1, V. Pisana1, G. Costantino1, A. Alibrandi2, W. Fries1

1University of Messina, Department of Clinical and Experimental Medicine, Messina, Italy, 2University of Messina, Department of Economics, Messina, Italy

P235: Does pregnancy adversely impact the health-related quality of life among women with IBD?ECCO '18 Vienna
Year: 2018
Authors:

N. Rodriguez1*, L. Ambrosio2, R. Sutton3, L. Dieleman3, B. Halloran3, K. Kroeker2, F. Peerani3, K. Wong3, R. Fedorak4, V. Huang3

1University of Alberta, Biological Sciences and Psychology, Edmonton, Canada, 2University of Alberta, Zeidler Ledcor Center, Department of Gastroenterology, Edmonton, Canada, 3University of Alberta, Zeidler Ledcor Centre, Department of Gastroenterology, Edmonton, Canada, 4University of Alberta, Department of Medicine, Edmonton, Canada

P236: Symptoms of anxiety and depression in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J.C. Silva1*, A.P. Silva1, A. Rodrigues1, J. Rodrigues1, M. Sousa1, A.S. Machado2, J. Carvalho1

1Centro Hospitalar Vila Nova de Gaia/Espinho, Gastroenterology and Hepatology, Vila Nova de Gaia, Portugal, 2Centro Hospitalar São João, Psychiatry, Porto, Portugal

P237: Value of 75SeHCAT in the diagnosis of bile acid malabsorption in Crohn’s Disease with chronic diarrhoeaECCO '18 Vienna
Year: 2018
Authors:

B. Gros1*, L. Mena2,3, J.M. Benítez1,3, E. Carmona2, S. Marín1,3, F. Maza2, R. Medina3, V. García-Sánchez1,3, E. Iglesias-Flores1,3

1Reina Sofia University Hospital, Gastroenterology, Córdoba, Spain, 2Reina Sofia University Hospital, Nuclear Medicine, Córdoba, Spain, 3Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain

P238: A pilot study on the prevalence of obstructed defaecation syndrome among female patients of an inflammatory bowel disease cohortECCO '18 Vienna
Year: 2018
Authors:

E. Khoo1, S. Stanley1, K. Potter1, A. Cornish1, M. Hales1, L. Brett1, D. Shukla1*, C. Gillespie2, C. McIvor1

1Logan Hospital, Gastroenterology department, Meadowbrook, Australia, 2Queen Elizabeth II Hospital, Colorectal Surgery, Coopers Plains, Australia

P239: The accuracy of intestinal ultrasound as compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileo-colonoscopyECCO '18 Vienna
Year: 2018
Authors:

D. Carter*, L.H. Katz, E. Bardan, E. Salomon, S. Goldstein, S. Ben Horin, U. Kopylov, R. Eliakim

Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel

P240: Microscopic colitis is the most frequent diagnosis of patients with watery chronic diarrhoea and macroscopically normal colonoscopy in a context of clinical practiceECCO '18 Vienna
Year: 2018
Authors:

L. Batista1*, L. Ruiz1, Y. Zabana1, M. Aceituno1, B. Arau1, X. Andújar1, M. Esteve1, F. Fernández-Bañares1,2

1Hospital Universitari Mutua Terrassa, Gastroenterology, Terrassa, Spain, 2CIBERehd, Terrassa, Spain

P241: Predictive factors of bone loss in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Hammami*, B. Hasnaoui, M. Ksiaa, H. Jaziri, N. Elleuch, A. Brahem, S. Ajmi, A. Ben Slama, A. Jmaa

Hospital University of Sahloul, Gastroenterology, Sousse, Tunisia

P242: The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

D.J. Oh1, H. Yoon1*, Y.J. Choi1, C.M. Shin1, Y.S. Park1, N. Kim1,2, D.H. Lee1,2

1Seoul National University Bundang Hospital, Internal medicine, Seongnam, South Korea, 2Seoul National University College of Medicine, Internal Medicine and Liver Research Institute, Seoul, South Korea

P243: Colectomy rates in ulcerative colitis are low and decreasing: Ten-year follow-up data from the Swiss IBD cohort studyECCO '18 Vienna
Year: 2018
Authors:

L. Parragi1, N. Fournier2, J. Zeitz3, M. Scharl1, T. Greuter1, P. Schreiner1, B. Misselwitz1, E. Safroneeva4, A. Schoepfer5, S.R. Vavricka6, G. Rogler1, L. Biedermann on behalf of the Swiss IBD Cohort Study Group7*

1University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Lausanne, IUMSP, Lausanne, Switzerland, 3Klinik Hirslanden, Department of Gastroenterology, Zurich, Switzerland, 4University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 5CHUV - Centre Hospitalier Universitaire Vaudois, Department of Gastroenterology, Lausanne, Switzerland, 6Hospital Triemli, Gastroenterology and Hepatology, Zurich, Switzerland, 7University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland

P244: Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseasesECCO '18 Vienna
Year: 2018
Authors:

A. Buisson1,2*, W.Y. Mak3,4, M.J. Andersen Jr4, D. Lei4, S.A. Kahn4, J. Pekow4, R.D. Cohen4, N. Zmeter4, B. Pereira5, D.T. Rubin4

1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the Host, Clermont-Ferrand, France, 3Queen Elizabeth Hospital, Department of Medicine, Hong Kong, Hong Kong, 4Inflammatory Bowel Disease Center University of Chicago Medicine, Chicago, USA, 5University Hospital, Biostatistics Unit, DRCI, Clermont-Ferrand, France

P245: Development and validation of a Simplified Magnetic Resonance Index of Activity (sMaARIA) for Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

I. Ordas1*, J. Rimola2, I. Alfaro1, S. Rodriguez2, J. Castro1, M. Gallego1, A. Giner1, R. Barastegui1, A. Vara1, M. Masamunt1, E. Ricart1, J. Panes1

1Hospital Clinic Barcelona, Gastroenterology, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain, 2University Hospital Clinic de Barcelona, Department of Radiology, CIBER-EHD, IDIBAPS, Barcelona, Spain

P246: The association of serum 7α-hydroxy-4-cholesten-3-one (7C4) with Bile Acid Diarrhoea in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

R. Battat1,2*, M. Duijvestein2, N. Vande Casteele2,3, S. Singh1, M. Renshaw4, J. McFarland4, H. Chen4, A. Jain4, W.J. Sandborn3, B.S. Boland3

1University of California, San Diego, Division of Gastroenterology, La Jolla, USA, 2Robarts Clinical Trials, La Jolla, USA, 3University of California, Division of Gastroenterology, La Jolla, USA, 4Prometheus Laboratories Inc., La Jolla, USA

P247: MR enterography in Crohn’s disease: Comparison between diffusion-weighted imaging and intravenous contrast material in detection of active diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Geccherle1, A. Variola1*, A. Massella1, E. Demozzi2, E. Oliboni2, G. Carbognin2, L. Romano2

1Ospedale Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2Ospedale Sacro Cuore Don Calabria, Radiology, Negrar, Italy

P248: IL-33/ST2 levels can predict mucosal response to anti-TNF therapy in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

L.R. Lopetuso1,2*, V. Petito1, C. Graziani1, T.T. Pizarro2, A. Armuzzi1, A. Gasbarrini1, F. Scaldaferri1

1Catholic University of Sacred Heart, Internal Medicine Department, Gastroenterology Division, Rome, Italy, 2Case Western Reserve University, Pathology, Cleveland, USA

P249: Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healingECCO '18 Vienna
Year: 2018
Authors:

T. Yamamoto*, T. Shimoyama, S. Umegae

Yokkaichi Hazu Medical Centre, Inflammatory Bowel Disease Centre, Yokkaichi, Japan

P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world studyECCO '18 Vienna
Year: 2018
Authors:

A. Afzali1*, X. Song2, N. Shi2, M. Skup3, W.-J. Lee3

1The Ohio State University – Wexner Medical Center, Columbus, USA, 2Truven Health Analytics, an IBM Company, Cambridge, USA, 3AbbVie Inc., North Chicago, USA

P251: High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseasesECCO '18 Vienna
Year: 2018
Authors:

G. Bodini1*, M.G. Demarzo1, M. Saracco1, C. Coppo1, I. Baldissarro1, J. Anjali2, E. Savarino3, V. Savarino1, E. Giannini1

1Policlinico San Martino, University of Genoa, Department of Internal Medicine, Genoa, Italy, 2Prometheus Laboratories, Department of Research and Development, San Diego, California, USA, 3University of Padua, Department of Surgery, Oncology and Gastroenterology, Padova, Italy

P252: Assessment of ulcerative colitis using histological indexesECCO '18 Vienna
Year: 2018
Authors:

F. Magro1,2,3, J. Lopes4, P. Borralho5, S. Lopes6, R. Coelho6, J. Cotter7, F. Dias de Castro7, H. T. Sousa8, P. Lago9, M. Salgado9, P. Andrade6, A.I. Vieira10, P. Figueiredo10, P. Caldeira11, A. Sousa11, M.A. Duarte12, F. Ávila12, J. Silva13, J. Moleiro13, S. Mendes14, S. Giestas14, P. Ministro15, P. Sousa15, R. Gonçalves16, B. Gonçalves16, A. Oliveira17, I. Rosa18, M. Rodrigues4, C. Chagas19, J. Torres20, C.C. Dias21,22, J. Afonso1,3*, K. Geboes23, F. Carneiro4,24

1Faculty of Medicine, University of Porto,, Department of Biomedicine, Unit of Pharmacology and Therapeutics, Porto, Portugal, 2Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal, 3Centre for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal, 4Faculty of Medicine, Centro Hospitalar Sao Joao, Department of Pathology, Porto, Portugal, 5Faculty of Medicine, University of Lisbon, Institute of Pathology, Lisbon, Portugal, 6Centro Hospitalar São Joao, Department of Gastroenterology, Porto, Portugal, 7Hospital da Senhora da Oliveira, Department of Gastroenterology, Guimarães, Portugal, 8Centro Hospitalar do Algarve, Gastroenterology Department, Portimão, Portugal, 9Centro Hospitalar do Porto, Department of Gastroenterology, Porto, Portugal, 10Hospital Garcia de Orta, Department of Gastroenterology, Almada, Portugal, 11Centro Hospitalar do Algarve, Department of Gastroenterology, Faro, Portugal, 12Divino Espírito Santo Hospital, Department of Gastroenterology, Ponta Delgada, Portugal, 13Instituto Português do Oncologia de Lisboa, Department of Gastroenterology, Lisboa, Portugal, 14Centro hospitalar e Universitário de Coimbra, Department of Gastroenterology, Coimbra, Portugal, 15Centro Hospitalar Tondela-Viseu, Department of Gastroenterology, Viseu, Portugal, 16Hospital de Braga, Department of Gastroenterology, Braga, Portugal, 17Hospital Fernando da Fonseca, Department of Gastroenterology, Amadora, Portugal, 18Instituto Português de Oncologia de Lisboa,, Gastroenterology Department, Lisboa, Portugal, 19Centro Hospitalar Lisboa Ocidental, Department of Gastroenterology, Lisbon, Portugal, 20Hospital Beatriz Angelo, Department of Gastroenterology, Loures, Portugal, 21Faculty of Medicine, University of Porto, Health Information and Decision Sciences Department, Porto, Portugal, 22Center for Health Technology and Services Research, Porto, Portugal, 23University Hospital of KU Leuven and UZ Gent, Department of Pathology, Leuven, Belgium, 24Instituto de Investigação e Inovação na Saúde (I3S), Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal

P253: Characteristics of patients with Crohn’s disease diagnosed in the emergency department: Experience in a single tertiary hospitalECCO '18 Vienna
Year: 2018
Authors:

S.W. Lee1*, S.K. Kim1, E.S. Kim1, H.S. Lee2, Y.H. Kwon2, S.Y. Nam2, N. You1, J.S. Lee1, S. Jin1

1Kyungpook National University Hospital, Kyungpook National University School of Medicine, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea, 2Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Division of Gastroenterology, Department of Internal Medicine, Daegu, South Korea